Drug candidate treats severe fatty liver disease by protecting the gut in animal models
Peer-Reviewed Publication
Updates every hour. Last Updated: 30-Oct-2026 04:16 ET (30-Oct-2026 08:16 GMT/UTC)
Researchers at the University of Colorado Anschutz have developed a promising nonhormonal therapy for women experiencing Genitourinary Syndrome of Menopause (GSM). GSM is a common chronic condition caused by declining estrogen levels that affects the vulva, vagina and urinary tract, leading to symptoms such as vaginal dryness, painful intercourse, and recurrent vaginal and urinary tract infections.
Unlike over-the-counter treatments that may provide some temporary symptom relief, the new therapy is designed to restore estrogen signaling only within vaginal tissue, without exposing the rest of the body to estrogen.
In a preclinical animal study, the treatment restored the structure and function of vaginal tissue lost through estrogen deficiency, suggesting a potential way to address the underlying cause of GSM rather than simply managing its symptoms.
The findings were published today in Menopause.
“For too many women, the current options are either products that only provide temporary relief or hormone-based treatments they may not feel comfortable using,” said the paper’s senior author Steve Nordeen, PhD, professor emeritus, department of pathology at the CU Anschutz School of Medicine.
An estimated 50% to 70% of women experiencing natural or medically induced menopause develop one or more symptoms of GSM.
Sperm carry far more than DNA. As they develop in the testis and mature in the epididymis, they also carry a shifting set of chemical marks on RNA — a molecular layer that may help shape fertility and influence how paternal experiences are passed to the next generation.
Now, researchers have produced a detailed map of this changing “sperm RNA modification code.” In a study published in Science China Life Sciences, the team profiled 27 types of RNA modifications across mouse testis development, purified spermatogenic cells, sperm collected from different regions of the epididymis and a typeⅡdiabetes mellitus mouse model. The work reveals that sperm RNA modifications are not static labels, but a dynamic program that is written, erased and reorganized as sperm move toward maturity.
G protein-coupled receptors (GPCRs) are important therapeutic targets for numerous diseases. However, developing highly selective drugs for GPCRs remains a challenge. Researchers have now developed a new platform termed extracellular vesicle (EV)-Systematic Evolution of Ligands by Exponential Enrichment, which uses EVs to efficiently isolate potent DNA aptamers. Using this method, they identified an analgesic aptamer that targets µ-opioid receptor to mimic morphine-like activity, demonstrating the platform’s potential in accelerating drug discovery for GPCR-related conditions
Solving problems by harnessing the natural adaptive capacity of bacteria. This is the challenge taken up by a research team coordinated by INRAE and involving Grenoble Alpes University Hospital, Université Grenoble Alpes and the French Alternative Energies and Atomic Energy Commission (CEA). By tracking the growth curves of the bacterium Escherichia coli, the researchers were able to distinguish between mild and severe forms of COVID-19. These results, published in Cell Systems, pave the way for simple and low-cost diagnostic methods.
Can the trauma of a parent rewrite the mental health of a child born decades later? A new compelling study reveals that children born decades after the Holocaust to parents who were older than age five at the time of the initial Nazi persecutions faced elevated schizophrenia risk. This preconception echo underscores specific periods of vulnerability to trauma experienced in childhood and suggests that the shadows of atrocities can quietly reach across generations.
A molecule linked to chronic inflammation disrupts the brain’s ability to create new neurons – uncovering a pathway with therapeutic potential for neurodegenerative diseases and neurological conditions.